OGN

Organon & Co (OGN)

About Organon & Co (OGN)

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Details

Daily high

$6.92

Daily low

$6.75

Price at open

$6.80

52 Week High

$17.23

52 Week Low

$6.18

Market cap

1.8B

Dividend yield

4.98%

Volume

851,442

Avg. volume

4.7M

P/E ratio

3.55

Organon & Co News